BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23080029)

  • 1. [Carcinoma in situ of the testis].
    Dieckmann KP; Kliesch S; Schrader M; Krege S; Loy V
    Pathologe; 2012 Nov; 33 Suppl 2():376-7; author reply 378. PubMed ID: 23080029
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoma in situ in the testis.
    Rørth M; Rajpert-De Meyts E; Andersson L; Dieckmann KP; Fosså SD; Grigor KM; Hendry WF; Herr HW; Looijenga LH; Oosterhuis JW; Skakkebaek NE
    Scand J Urol Nephrol Suppl; 2000; (205):166-86. PubMed ID: 11144894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primitive neuroectodermal tumor of the testis. Molecular analysis and discussion of genesis].
    Brandt S; Lohe B; Vogetseder A; Rüdiger T; Moch H; Bode P
    Pathologe; 2013 Feb; 34(1):70-3. PubMed ID: 22706883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoma in situ of the testis: predisposition, evolution and early detection].
    Biermann K
    Pathologe; 2011 Nov; 32 Suppl 2():232-6. PubMed ID: 21850455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoma in situ of the testis: clinical significance, diagnosis and therapy].
    Dieckmann KP; Loy V; Huland H
    Urologe A; 1989 Sep; 28(5):271-80. PubMed ID: 2554553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryogenesis and metastatic testicular germ cell tumors of adolescents.
    Looijenga LH
    Klin Padiatr; 2009; 221(3):134-5. PubMed ID: 19437359
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoma in situ -from clinical observation to a paradigm shift for testicular carcinogenesis.
    Toppari J
    Int J Dev Biol; 2013; 57(2-4):221-3. PubMed ID: 23784833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of epigenetic modifiers in the pathogenesis of testicular dysgenesis and germ cell cancer.
    Lawaetz AC; Almstrup K
    Biomol Concepts; 2015 Jun; 6(3):219-27. PubMed ID: 26103631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis.
    Kristensen DG; Nielsen JE; Jørgensen A; Skakkebæk NE; Rajpert-De Meyts E; Almstrup K
    Br J Cancer; 2014 Feb; 110(3):668-78. PubMed ID: 24292451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer.
    Hoei-Hansen CE; Holm M; Rajpert-De Meyts E; Skakkebaek NE
    J Pathol; 2003 Jul; 200(3):370-4. PubMed ID: 12845633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral biopsies in patients with testicular germ-cell tumour-nuisance or new sense?
    Dieckmann KP
    Ann Oncol; 2015 Apr; 26(4):620-621. PubMed ID: 25600563
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
    Rajpert-De Meyts E
    Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: noninvasive detection of testicular carcinoma in situ in semen using OCT3/4.
    Clarke NW
    Eur Urol; 2008 Jul; 54(1):159-60. PubMed ID: 17996361
    [No Abstract]   [Full Text] [Related]  

  • 14. Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?
    von der Maase H
    Acta Oncol; 2005; 44(6):523-5. PubMed ID: 16165909
    [No Abstract]   [Full Text] [Related]  

  • 15. The fine structure of possible carcinoma-in-situ in the seminiferous tubules in the testis of four infertile men.
    Nielsen H; Nielsen M; Skakkebaek NE
    Acta Pathol Microbiol Scand A; 1974 Mar; 82(2):235-48. PubMed ID: 4364167
    [No Abstract]   [Full Text] [Related]  

  • 16. High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
    Shekhani MT; Barber JR; Bezerra SM; Heaphy CM; Gonzalez Roibon ND; Taheri D; Reis LO; Guner G; Joshu CE; Netto GJ; Meeker AK
    Hum Pathol; 2016 Aug; 54():106-12. PubMed ID: 27085557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: noninvasive detection of testicular carcinoma in situ in semen using OCT3/4.
    Giwercman A
    Eur Urol; 2008 Jul; 54(1):159. PubMed ID: 17996362
    [No Abstract]   [Full Text] [Related]  

  • 18. Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis.
    Oosterhuis JW; Looijenga LH
    APMIS; 2003 Jan; 111(1):280-9. PubMed ID: 12752274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITGCN of the testis, contralateral testicular biopsy and bilateral testicular cancer.
    Karellas ME; Damjanov I; Holzbeierlein JM
    Urol Clin North Am; 2007 May; 34(2):119-25; abstract vii. PubMed ID: 17484917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic features of testicular germ cell tumours in relation to epigenetic characteristics of foetal germ cells.
    Kristensen DG; Skakkebæk NE; Rajpert-De Meyts E; Almstrup K
    Int J Dev Biol; 2013; 57(2-4):309-17. PubMed ID: 23784842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.